India’s Zydus Lifesciences receives Final Clearance from US-FDA for Esomeprazole; Product will be manufactured at Moraiya facility

Pharmaceutical tablets and capsules are arranged on table in photo illustration

On Thursday, June 8, Indian pharmaceutical company Zydus Lifesciences Limited received final approval from the United States Food and Drug Administration (USFDA) for Esomeprazole Magnesium for Delayed-Release Oral Suspension 20 mg and 40 mg. Read Also: Cipla signs binding term sheet to sell its entire stake in Saba Investments; Deal worth US$6.50 million Zydus Lifesciences … Read more